Actemra is approved by the FDA for the treatment of several different medical conditions: Moderately to severely active rheumatoid arthritis in adult patients who have had an inadequate response to one or more Disease-Modifying Anti-Rheumatic Drugs (DMARDs); Giant Cell Arteritis (GCA) in adult patients; Polyarticular Juvenile Idiopathic … [Read more...]